Skip to main content

Main menu

  • Home
  • Current issue
  • Early View
  • Archive
  • For authors
    • Instructions for authors
    • Submit a manuscript
    • ERS Author FAQs
    • COVID-19 submission information
  • Alerts
  • Subscriptions
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

User menu

  • Log in
  • Subscribe
  • Contact Us
  • My Cart

Search

  • Advanced search
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

Login

European Respiratory Society

Advanced Search

  • Home
  • Current issue
  • Early View
  • Archive
  • For authors
    • Instructions for authors
    • Submit a manuscript
    • ERS Author FAQs
    • COVID-19 submission information
  • Alerts
  • Subscriptions

Time on therapy and concomitant medication use of mepolizumab in Canada: a retrospective cohort study

Jason K. Lee, Alain Gendron, Michelle Knutson, Niroshan Sriskandarajah, Lawrence Mbuagbaw, Stephen G. Noorduyn
ERJ Open Research 2021 7: 00778-2020; DOI: 10.1183/23120541.00778-2020
Jason K. Lee
1Evidence Based Medical Educator, Toronto, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Alain Gendron
2AstraZeneca, Mississauga, Canada
3Dept of Medicine, University of Montreal, Quebec, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Alain Gendron
Michelle Knutson
4University of Toronto, Toronto, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Niroshan Sriskandarajah
2AstraZeneca, Mississauga, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Lawrence Mbuagbaw
5Dept of Health Research Methods, Evidence and Impact, McMaster University, Hamilton, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Lawrence Mbuagbaw
Stephen G. Noorduyn
2AstraZeneca, Mississauga, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: Stephen.noorduyn@astrazeneca.com
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Figures

  • FIGURE 1
    • Download figure
    • Open in new tab
    • Download powerpoint
    FIGURE 1

    a) Kaplan–Meier survival curve for discontinuation. b) Trends in average monthly claims for rescue medications before, during and after use of mepolizumab. Bars represent means and error bars represent standard deviations. OCS: oral corticosteroid; SABA: short-acting β2-agonist. F-tests were performed for differences between groups.

PreviousNext
Back to top
Vol 7 Issue 1 Table of Contents
ERJ Open Research: 7 (1)
  • Table of Contents
  • Index by author
Email

Thank you for your interest in spreading the word on European Respiratory Society .

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Time on therapy and concomitant medication use of mepolizumab in Canada: a retrospective cohort study
(Your Name) has sent you a message from European Respiratory Society
(Your Name) thought you would like to see the European Respiratory Society web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Print
Alerts
Sign In to Email Alerts with your Email Address
Citation Tools
Time on therapy and concomitant medication use of mepolizumab in Canada: a retrospective cohort study
Jason K. Lee, Alain Gendron, Michelle Knutson, Niroshan Sriskandarajah, Lawrence Mbuagbaw, Stephen G. Noorduyn
ERJ Open Research Jan 2021, 7 (1) 00778-2020; DOI: 10.1183/23120541.00778-2020

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Time on therapy and concomitant medication use of mepolizumab in Canada: a retrospective cohort study
Jason K. Lee, Alain Gendron, Michelle Knutson, Niroshan Sriskandarajah, Lawrence Mbuagbaw, Stephen G. Noorduyn
ERJ Open Research Jan 2021, 7 (1) 00778-2020; DOI: 10.1183/23120541.00778-2020
del.icio.us logo Digg logo Reddit logo Technorati logo Twitter logo CiteULike logo Connotea logo Facebook logo Google logo Mendeley logo
Full Text (PDF)

Jump To

  • Article
    • Abstract
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • PDF

Subjects

  • Pulmonary pharmacology and therapeutics
  • Asthma and allergy
  • Tweet Widget
  • Facebook Like
  • Google Plus One

More in this TOC Section

  • High-dose glucocorticoid treatment of near-fatal bocavirus
  • Pathological changes in the airway epithelium in COVID-19
  • Pneumatocoeles after BLVR with valves
Show more Original research letters

Related Articles

Navigate

  • Home
  • Current issue
  • Archive

About ERJ Open Research

  • Editorial board
  • Journal information
  • Press
  • Permissions and reprints
  • Advertising

The European Respiratory Society

  • Society home
  • myERS
  • Privacy policy
  • Accessibility

ERS publications

  • European Respiratory Journal
  • ERJ Open Research
  • European Respiratory Review
  • Breathe
  • ERS books online
  • ERS Bookshop

Help

  • Feedback

For authors

  • Instructions for authors
  • Submit a manuscript
  • ERS author centre

For readers

  • Alerts
  • Subjects
  • RSS

Subscriptions

  • Accessing the ERS publications

Contact us

European Respiratory Society
442 Glossop Road
Sheffield S10 2PX
United Kingdom
Tel: +44 114 2672860
Email: journals@ersnet.org

ISSN

Online ISSN: 2312-0541

Copyright © 2021 by the European Respiratory Society